β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats

Chem Biol Interact. 2016 Feb 5:245:50-8. doi: 10.1016/j.cbi.2015.12.019. Epub 2015 Dec 31.

Abstract

Oxidative and inflammatory stress has been implicated in the onset and progression of diabetes mellitus and its complications. The present study was designed to evaluate the effect of β-Caryophyllene (BCP) on hyperglycemia mediated oxidative and inflammatory stress in streptozotocin (STZ) induced diabetic rats. Diabetes was induced in experimental rats by a single intraperitoneal injection of STZ (40 mg/kg b.w.) dissolved in 0.1 M citrate buffer (pH 4.5). Diabetic rats exhibited increased blood glucose with significant decrease in plasma insulin levels. The activities of antioxidant enzymes and the levels of non-enzymic antioxidants were decreased while increases in the levels of lipidperoxidative markers, protein carbonyls and conjugated dienes were observed in pancreatic tissues of diabetic rats. An elevation of proinflammatory cytokines tumor necrosis factor-α and interleukin-6 were observed in plasma and pancreatic tissues of diabetic rats. Intragastric administration of BCP (200 mg/kg b.w) for 45 days significantly decreased glucose and increased insulin levels in diabetic rats. BCP administration significantly restored antioxidant status and decreased proinflammatory cytokines in diabetic rats. These findings were supported by histological and immunohistochemical studies. Thus, we conclude that oral administration of BCP effectively rescued β-cells by mitigating hyperglycemia through enhancing insulin release and also averted oxidative/inflammatory stress in pancreatic tissue of diabetic rats. The efficacy of BCP was compared with glibenclamide, a standard antidiabetic drug.

Keywords: Antioxidants; Cytokines; Diabetes; Streptozotocin; β-Caryophyllene.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antioxidants / therapeutic use*
  • Diabetes Mellitus, Experimental / complications
  • Diabetes Mellitus, Experimental / drug therapy*
  • Diabetes Mellitus, Experimental / immunology
  • Diabetes Mellitus, Experimental / metabolism
  • Hyperglycemia / complications
  • Hyperglycemia / drug therapy*
  • Hyperglycemia / immunology
  • Hyperglycemia / metabolism
  • Hypoglycemic Agents / therapeutic use
  • Inflammation / complications
  • Inflammation / drug therapy*
  • Inflammation / immunology
  • Inflammation / metabolism
  • Interleukin-6 / blood
  • Interleukin-6 / immunology
  • Male
  • Oxidative Stress / drug effects*
  • Polycyclic Sesquiterpenes
  • Rats, Wistar
  • Sesquiterpenes / therapeutic use*
  • Tumor Necrosis Factor-alpha / blood
  • Tumor Necrosis Factor-alpha / immunology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Hypoglycemic Agents
  • Interleukin-6
  • Polycyclic Sesquiterpenes
  • Sesquiterpenes
  • Tumor Necrosis Factor-alpha
  • caryophyllene